Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Strategic planning for applied pharmacoeconomics programs.

L A Wanke1, G M Ryan

  • 1M.D. Anderson Cancer Center, Houston, TX 77030, USA.

Pharmacy Practice Management Quarterly
|December 9, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules.

Journal of viral hepatitis·2003
Same author

Direct and indirect costs of rheumatoid arthritis to an employer.

Journal of occupational and environmental medicine·2000
Same author

An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline.

Arthritis and rheumatism·1999
Same author

Designer drugs: the evolving science of drug discovery.

Pharmacy practice management quarterly·1998
Same author

Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
Same author

New approaches and technologies in drug design and discovery.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1995
Same journal

Survey of standards and guidelines for immunization delivery.

Pharmacy practice management quarterly·2001
Same journal

Somebody else's antibodies: the characteristics and roles of immune globulins.

Pharmacy practice management quarterly·2001
Same journal

Targeting vaccines based on underlying disease states.

Pharmacy practice management quarterly·2001
Same journal

Overcoming immunization disparities based on ethnicity.

Pharmacy practice management quarterly·2001
Same journal

Immunization and organ transplant donors and recipients.

Pharmacy practice management quarterly·2001
Same journal

Pregnancy and lactation in relation to vaccines and antibodies.

Pharmacy practice management quarterly·2001
See all related articles

Rising healthcare costs necessitate demonstrating value in drug therapy. Pharmacoeconomics programs, like those at M.D. Anderson and Oregon Health Sciences University, ensure optimal outcomes for pharmaceutical spending.

Area of Science:

  • Health economics
  • Pharmaceutical policy
  • Healthcare management

Background:

  • Healthcare costs are escalating, impacting service delivery infrastructure.
  • Managed care and national health plans aim to control rising drug therapy expenses.
  • Demonstrating value for money is crucial amid increasing demand and shrinking resources.

Purpose of the Study:

  • To present pharmacoeconomics as a mechanism for establishing the value of drug therapy.
  • To illustrate the development of applied pharmacoeconomics programs in healthcare settings.
  • To showcase case studies from M.D. Anderson Cancer Center and Oregon Health Sciences University.

Main Methods:

  • Strategic planning process utilized for program development.
  • Case study approach examining two distinct healthcare institutions.

Related Experiment Videos

  • Focus on integrating pharmacoeconomics into pharmaceutical services.

    • Main Results:

    • Successful development of pharmacoeconomics programs in leading cancer and university hospitals.
    • Programs established to ensure optimal outcomes from drug therapy expenditures.
    • Defined activities essential for an applied pharmacoeconomics program.

    Conclusions:

    • Pharmacoeconomics is vital for demonstrating the value of drug therapy in cost-constrained environments.
    • Applied pharmacoeconomics programs can be developed using strategic planning.
    • These programs ensure efficient allocation of resources for pharmaceutical services and drug therapy.